Pharmacovigilance

DSA offers a range of pharmacovigilance services to DSA Clients.  Each client relationship is different, and services offered can range from DSA holding all of the Canadian PV responsibility to a shared responsibility with the client or other parties.  Our services include:

  • Writing SOPs to govern the Canadian pharmacovigilance program.
  • Establishing safety profiles 
  • Preparing agreements such as Safety Data Exchange Agreements for Canada or Pharmacovigilance Agreements
  • Reporting domestic serious unexpected and unexpected adverse drug reactions (ADR) to Health Canada
  • Reporting foreign serious unexpected adverse drug reactions (ADR) to Health Canada
  • Reporting Lack of Efficacy for new drugs
  • Monitoring and Reporting Foreign Actions to comply with C.01.050
  • Monitoring Regulatory Authorities Sources
  • Monitoring Scientific Literature
  • Preparing Annual Summary Reports or Periodic Safety Update Reports (PSUR)
  • Preparing Annual Periodic Benefit-Risk Evaluation Report (PBRER)
  • Preparing Issue Related Summary Reports
  • Conducting Signal Detection Reviews
  • Conducting PV Self-Inspections or PV Audits of other service providers.
  • Qualified Healthcare Practitioners on staff to meet Canadian requirements

Download

Contact us to find out more about our regulatory consulting services or download a free copy of our DSA Whitepaper on marketing a health care product in Canada.

Follow Us